Status:
COMPLETED
Short-term Prednisone to Treat STA Study(SPTSS)
Lead Sponsor:
Xinqiao Hospital of Chongqing
Conditions:
Subacute Thyroiditis
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
Efficiency and Safety Study of Short-term Prednisone to Treat Moderate and Severe Subacute Thyroiditis The investigators hypothesize that less adverse reactions will be observed, comparing with the g...
Detailed Description
Comparing with the guidelines recommend, short-term (one week)prednisone and nsaids following up next week to treat moderate and severe subacute thyroiditis will be assessed. The patients in wards wi...
Eligibility Criteria
Inclusion
- 18-70 years patients with Moderate and severe subacute thyroiditis
Exclusion
- adrenal cortical dysfunction,
- use of corticosteroids in nearly three months,
- mild subacute thyroiditis,
- non-onset STA,
- family history of diabetes,
- gastric ulcer,
- the special medication history,
- heart，liver and renal insufficiency,
- tumors,
- tuberculosis and
- poor compliance.
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01837433
Start Date
March 1 2013
End Date
December 1 2014
Last Update
May 20 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second Affiliated Hospital, Third Military Medical University
Chongqing, Chongqing Municipality, China, 400037